SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) WHIPPANY, N.J., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Halo ...
Symbiosis Pharmaceutical Services appoints Jay Chima as VP - business development in response to growing demand for biologics ...
TOKYO--(BUSINESS WIRE)--Rigaku Corporation, a Group company of Rigaku Holdings Corporation (headquarters: Akishima, Tokyo; CEO: Jun Kawakami; hereinafter “Rigaku”), and SPERA PHARMA, Inc.
Centrix and University of Sussex launch a data analytics partnership to reduce development risk, rework and delays in early-stage pharma programs. A collaboration between Centrix Pharma Solutions, a ...
Following the Council of the European Union and the European Parliament reaching an agreement in the trilogue negotiations on the so-called Pharma Package in December 2025, the texts of the ...
Hosted on MSN
Pharma giants accelerate new drug development
Domestic pharmaceutical companies have been expanding their research and development (R&D) investments this year. They are pouring money earned overseas into new drug development to build foundational ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results